• Title of article

    CRL4B Catalyzes H2AK119 Monoubiquitination and Coordinates with PRC2 to Promote Tumorigenesis

  • Author/Authors

    Hu، نويسنده , , Huili and Yang، نويسنده , , Yang and Ji، نويسنده , , Qinghong and Zhao، نويسنده , , Wei and Jiang، نويسنده , , Baichun and Liu، نويسنده , , Ruiqiong and Yuan، نويسنده , , Jupeng and Liu، نويسنده , , Qiao and Li، نويسنده , , Xi-Sheng Zou، نويسنده , , Yongxin and Shao، نويسنده , , Changshun and Shang، نويسنده , , Yongfeng and Wang، نويسنده , , Yan-dan Gong، نويسنده , , Yaoqin، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2012
  • Pages
    15
  • From page
    781
  • To page
    795
  • Abstract
    Summary orted that Cullin4B-Ring E3 ligase complex (CRL4B) is physically associated with Polycomb-repressive complex 2 (PRC2). We showed that CRL4B possesses an intrinsic transcription repressive activity by promoting H2AK119 monoubiquitination. Ablation of Cul4b or depletion of CUL4B, the main component of CRL4B, resulted in loss of not only H2AK119 monoubiquitination but also H3K27 trimethylation, leading to derepression of target genes that are critically involved in cell growth and migration. We demonstrated that CUL4B promotes cell proliferation, invasion, and tumorigenesis in vitro and in vivo and found that its expression is markedly upregulated in various human cancers. Our data indicate that CUL4B promotes tumorigenesis, supporting the pursuit of CUL4B as a target for cancer therapy.
  • Journal title
    Cancer Cell
  • Serial Year
    2012
  • Journal title
    Cancer Cell
  • Record number

    1338119